Skip to Content
Merck
  • Photoredox-catalyzed deuteration and tritiation of pharmaceutical compounds.

Photoredox-catalyzed deuteration and tritiation of pharmaceutical compounds.

Science (New York, N.Y.) (2017-11-11)
Yong Yao Loh, Kazunori Nagao, Andrew J Hoover, David Hesk, Nelo R Rivera, Steven L Colletti, Ian W Davies, David W C MacMillan
ABSTRACT

Deuterium- and tritium-labeled pharmaceutical compounds are pivotal diagnostic tools in drug discovery research, providing vital information about the biological fate of drugs and drug metabolites. Herein we demonstrate that a photoredox-mediated hydrogen atom transfer protocol can efficiently and selectively install deuterium (D) and tritium (T) at α-amino sp3 carbon-hydrogen bonds in a single step, using isotopically labeled water (D2O or T2O) as the source of hydrogen isotope. In this context, we also report a convenient synthesis of T2O from T2, providing access to high-specific-activity T2O. This protocol has been successfully applied to the high incorporation of deuterium and tritium in 18 drug molecules, which meet the requirements for use in ligand-binding assays and absorption, distribution, metabolism, and excretion studies.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
4CzIPN, ≥99.9%
Sigma-Aldrich
[Ir(p-F(Me)ppy)2-(4,4′-dtbbpy)]PF6, ≥95%